Results 41 to 50 of about 26,273 (196)

Portopulmonary hypertension practice patterns after liver transplantation

Liver Transplantation, EarlyView., 2022
Abstract Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...
Arun Jose, Elizabeth J. Kopras, Shimul A. Shah, Jean M. Elwing   +3 more
wiley   +1 more source

MELD–Na as a prognostic score for cirrhotic patients

Journal de la Faculté de Médecine d'Oran, 2023
Background-The high mortality of cirrhosis is a global public health problem. For predicting the outcome of patients with cirrhosis, many prognostic models were proposed.The new Model for End-Stage Liver Disease including serum sodium (MELD-Na) has been ...
Yousra Meguenni, Zineb Tahiri, Ibtissem Kihel, Mourad Nachi, Nazim Korti, Benali Addad   +5 more
doaj  

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. [PDF]

PLoS ONE, 2013
Allocation of donor livers for transplantation in most regions is based on the Model for End-Stage Liver Disease (MELD) or MELD-sodium (MELDNa). Our objective was to assess revisions to MELD and MELDNa that include serum albumin for predicting waiting ...
Robert P Myers, Abdel Aziz M Shaheen, Peter Faris, Alexander I Aspinall, Kelly W Burak   +4 more
doaj   +1 more source

Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.

Journal of Hepatology, 2020
BACKGROUND AND AIM Among candidates listed for liver transplant (LT), MELD score may not capture acute on chronic liver failure (ACLF) severity. Data on interaction between ACLF and MELD score in predicting waitlist (WL) mortality are scanty.
M. Abdallah, Y. Kuo, Sumeet K. Asrani, R. Wong, Aijaz Ahmed, P. Kwo, N. Terrault, P. Kamath, R. Jalan, A. Singal   +9 more
semanticscholar   +1 more source

Clostridioides difficile Infection and Liver Cirrhosis – A Retrospective, Cohort Study

Clinical and Experimental Gastroenterology, 2021
Nikhitha Mantri,1 Harish Patel,1,2 Kanthi Rekha Badipatla,1,2 Haozhe Sun,1 Danial Shaikh,1,2 Sudharsan Gongati,1 Suresh Kumar Nayudu1,2 1Department of Medicine, Bronx Care Health System, Affiliated with Icahn School of Medicine at Mount Sinai, Bronx, NY,
Mantri N, Patel H, Badipatla KR, Sun H, Shaikh D, Gongati S, Nayudu SK   +6 more
doaj  

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea [PDF]

The Korean Journal of Internal Medicine
Background/Aims The model for end-stage liver disease (MELD) serves as an indicator for short-term mortality among patients diagnosed with liver cirrhosis (LC) and is used to prioritize patients for liver transplantation.
Jeong Han Kim, Yong Joon Cho, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo   +4 more
doaj   +1 more source

The Development and Appraisal of MELD 3.0 in Liver Diseases: Good Things Never Come Easy

Journal of Clinical and Translational Hepatology
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver transplantation, serving as the primary criterion for organ ...
Gaoyue Guo, Wan-Ting Yang, Jia Li, Ziyi Yang, Jing Liang, Chao Sun   +5 more
semanticscholar   +1 more source

RISK STRATIFICATION IN CIRRHOTIC PATIENTS UNDERGOING NONHEPATIC SURGERY –LITERATURE REVIEW

Trakia Journal of Sciences
Liver cirrhosis is a socially significant chronic disease affecting people of working age that leads to severe, life-threatening complications in the absence of adequate treatment.
E. Merashka
doaj   +1 more source

Correlation of Sarcopenia with Etiologies of Liver Cirrhosis and Its Association with Child-Pugh and MELD Scores

National Board of Examinations Journal of Medical Sciences
Background: Sarcopenia, defined by the progressive decline in muscle mass and strength, is a common yet often overlooked complication in individuals with liver cirrhosis. The extent of muscle loss varies based on the underlying cause of cirrhosis and may
Navpreet Kaur Batth, Pulkit Jindal, Satarla Narendra, Deepak Sha K, Syamala Viswanadha Reddy   +4 more
doaj   +1 more source

CAR‐Engineered Cell Therapies Beyond Cancer: Reprogramming Fibrosis and Immune‐Mediated Inflammation

Advanced Science, EarlyView.
CAR‐engineered cell therapies are expanding beyond cancer toward immune resetting, pathological‐cell clearance, matrix remodeling, and microenvironmental reprogramming in autoimmune, inflammatory, and fibrotic diseases. This Review compares CAR‐T, CAR‐macrophage, and CAR‐NK platforms and proposes controllable spatiotemporal reprogramming to align ...
Peng Jun Xu, Zhou Jing Zhang, Jing Jin, Hai Yuan Xu, Ya Xin Gu, Qian Qian Yang, You Lang Zhou   +6 more
wiley   +1 more source